Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Cell. 2011 Feb 15;19(2):165-7. doi: 10.1016/j.ccr.2011.01.047.

PARP inhibitors in cancer therapy: promise, progress, and puzzles.

Author information

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, 02114, USA. ellisen@helix.mgh.harvard.edu

Abstract

A recent article in the New England Journal of Medicine by O'Shaughnessy et al. provides evidence that a treatment strategy aimed at inducing DNA damage with chemotherapy while simultaneously disabling repair using a PARP inhibitor might offer hope for patients with a treatment-refractory form of breast cancer.

Copyright © 2011 Elsevier Inc. All rights reserved.

Comment on

PMID:
21316599
[PubMed]
PMCID:
PMC3070420
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk